Form 4: BeOne Medicines General Counsel Sells Shares for Tax Withholding Following RSU Vesting

BeOne Medicines Ltd.'s SVP and General Counsel, Lee Chan Henry, sold 700 American Depositary Shares (ADS) for approximately $179,000 to cover tax obligations related to the vesting of a restricted share unit award.

Summary

• Lee Chan Henry, SVP and General Counsel of BeOne Medicines Ltd. (ONC), reported the sale of American Depositary Shares (ADS).
• The transactions occurred on June 6, 2025.
• A total of 700 American Depositary Shares were disposed of.
• The first sale involved 470 ADSs at a weighted average price of $255.7813 per ADS, with prices ranging from $255.46 to $256.3911.
• The second sale involved 230 ADSs at a weighted average price of $256.7942 per ADS, with prices ranging from $256.4629 to $256.98.
• The sales were executed to satisfy mandatory tax withholding provisions associated with the vesting of a restricted share unit award.
• Following these transactions, Lee Chan Henry beneficially owns 237,042 Ordinary Shares directly and 0 American Depositary Shares directly.
• Each American Depositary Share represents 13 Ordinary Shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale for tax withholding purposes, which is a common and expected event for executive compensation and does not imply a change in the insider's view of the company's value.

Future Outlook

The restricted share unit award has a vesting schedule where 1/4th of the securities will vest on each anniversary of June 5, 2024, contingent on continued service. Additionally, unvested securities are subject to accelerated vesting under specific termination events following a change in control.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a sale for tax withholding purposes, which is a common practice in executive compensation and does not typically reflect a change in management's outlook on the company's prospects. It is standard for executives to sell a portion of vested equity awards to cover tax liabilities.

Stakeholder Impact

• Shareholders: The sale is a routine tax-related transaction and is unlikely to have a significant direct impact on existing shareholders, as it does not signal a change in company fundamentals or management's confidence.

Next Steps

• Continued vesting of restricted share units on each anniversary of June 5, 2024, subject to continued service.

Key Dates

Keywords

BeOne Medicines, ONC, SEC Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Share Units, RSU Vesting, Executive Compensation, American Depositary Shares, ADS